Skip to content

GeneDx Holdings WGS Interest coverage

Interest coverage at other companies

Natera, Inc. logo
Natera, Inc.NTRA
-81.9×-157×
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
-4×-1.6×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
22.7×+17.6×
Labcorp Holdings logo
Labcorp HoldingsLH
6.4×+1.4×
Illumina logo
IlluminaILMN
8.5×
Agilent Technologies logo
Agilent TechnologiesA
14.8×+2.0×

Other financials

Income statement

See full
Revenue$102.3M+17.4%
Gross profit$68.2M+16.6%
Operating income-$57.5M-1,163%
Net income-$63.3M-870%
EPS (diluted)-$2.16-839%

Balance sheet

See full
Cash & equivalents$94.9M-5.7%
Total debt$96.7M+82.5%
Total equity$254.1M-1.3%
Total assets$506.3M+13.4%

Cash flow

See full
Operating cash flow-$32.4M-418%
CapEx$6.5M+5.3%
Free cash flow-$38.9M-1,059%

Valuation

See full
Market cap$1.72B-24.3%
Enterprise value$1.73B-22.8%
P/S3.9×-3.0×

Profitability

See full
Gross margin69.6%+4.3pp
Operating margin-14.9%
Net margin-17.6%
FCF margin3.8%+2.1pp

Returns & leverage

See full
Return on equity-30.4%
Debt / equity0.4×+0.2×
Current ratio3.1×-0.2×

Where this comes from

Calculated from GeneDx Holdings’s reported figures.

Based on trailing twelve months.

The official record: GeneDx Holdings’s 10-Q, filed October 29, 2024, on SEC EDGAR. View the filing →

Ask your AI about GeneDx Holdings's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GeneDx Holdings's interest coverage?
GeneDx Holdings (WGS) reported interest coverage of -147.7× in Q3 2023.
How has GeneDx Holdings's interest coverage changed year-over-year?
GeneDx Holdings's interest coverage decreased by 0.2% year-over-year, from -147.4× to -147.7×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.